Actinium Reports Promising Outcome of Actimab-A + CLAG-M Study at Prestigious Conference
Tuesday, 11 June 2024, 11:52
Actinium Announces Positive Results
The recent presentation by Actinium at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting showcased the successful synergy of Actimab-A + CLAG-M in a clinical trial.
Potential Breakthrough in Cancer Treatment
The combination showed promising results, indicating a potential breakthrough in cancer treatment.
Significant Advancement in the Field
This advancement marks a significant step forward in the field of nuclear medicine and molecular imaging.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.